Verona Pharma plc (VRNA)
NASDAQ: VRNA · IEX Real-Time Price · USD
15.46
-0.05 (-0.32%)
At close: Jul 2, 2024, 4:00 PM
15.45
-0.01 (-0.06%)
After-hours: Jul 2, 2024, 7:20 PM EDT

Verona Pharma Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
79
Market Cap
1.17B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 2022458.00K-39.54M-98.86%
Dec 31, 202140.00M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AtriCure 414.60M
Xencor 162.18M
Arcutis Biotherapeutics 106.39M
Prothena Corporation 89.25M
Immatics 80.95M
4D Molecular Therapeutics 20.45M
Spyre Therapeutics 688.00K
Revenue Rankings